Literature DB >> 20443408

[The university hospital palliative care team's approach to the transfer of end-stage cancer patients from hospital care to home medical care].

Kazuho Yoshino1, Noboru Nishiumi, Nobuhisa Kushino, Michiko Tsukada, Sachiko Douzono, Yuki Saito, Mitsunori Yagame, Yutaka Tokuda.   

Abstract

The palliative care team's roles are to provide a symptom relief to cancer patients, help them accept their medical conditions, and offer advice regarding the selection of appropriate medical treatments to suit their needs. Seeking the comfort of their homes, patients prefer a home care of superior medical care provided at hospitals. In 2008, 25 of the end-stage cancer patients at hospitals were expressed their desires to have a home medical care, and 10 of them were allowed to do so. We considered the following contributing factors that a patient should have for a smooth transition from hospital care to home medical care: (1) life expectancy of more than 2 months, (2) no progressive breathing difficulties experienced daily, (3) good awareness of medical condition among patients and families, (4) living with someone who has a good understanding of the condition, (5) availability of an appropriate hospital in case of a sudden change in medical requirements, and (6) good collaboration between emergency care hospitals, home physicians, and visiting nurses. To treat the end-stage cancer patients at home, there is a need for information sharing and a joint training of physicians specialized in cancer therapy, palliative care teams, home physicians, and visiting nurses. This would ensure a sustainable "face-to-face collaboration" in community health care.

Entities:  

Mesh:

Year:  2009        PMID: 20443408

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Care trajectories and survival after discharge from specialized inpatient palliative care--results from an observational follow-up study.

Authors:  Franziska Kötzsch; Stephanie Stiel; Maria Heckel; Christoph Ostgathe; Carsten Klein
Journal:  Support Care Cancer       Date:  2014-08-22       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.